Correlation Between Argenx NV and Quantum BioPharma

Can any of the company-specific risk be diversified away by investing in both Argenx NV and Quantum BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Argenx NV and Quantum BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between argenx NV ADR and Quantum BioPharma, you can compare the effects of market volatilities on Argenx NV and Quantum BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Argenx NV with a short position of Quantum BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Argenx NV and Quantum BioPharma.

Diversification Opportunities for Argenx NV and Quantum BioPharma

-0.4

Correlation Coefficient

Argenx NV  Quantum BioPharma

Very good diversification

The 3 months correlation between Argenx and Quantum is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding argenx NV ADR and Quantum BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum BioPharma and Argenx NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on argenx NV ADR are associated (or correlated) with Quantum BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum BioPharma has no effect on the direction of Argenx NV i.e., Argenx NV and Quantum BioPharma go up and down completely randomly.

Pair Corralation between Argenx NV and Quantum BioPharma

Given the investment horizon of 90 days argenx NV ADR is expected to generate 0.17 times more return on investment than Quantum BioPharma. However, argenx NV ADR is 5.85 times less risky than Quantum BioPharma. It trades about 0.18 of its potential returns per unit of risk. Quantum BioPharma is currently generating about -0.04 per unit of risk. If you would invest  35,948  in argenx NV ADR on October 9, 2024 and sell it today you would earn a total of  28,589  from holding argenx NV ADR or generate 79.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

argenx NV ADR  vs.  Quantum BioPharma

argenx NV ADR

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in argenx NV ADR are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady technical and fundamental indicators, Argenx NV showed solid returns over the last few months and may actually be approaching a breakup point.

Quantum BioPharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Quantum BioPharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Quantum BioPharma may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Argenx NV and Quantum BioPharma

The main advantage of trading using opposite Argenx NV and Quantum BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Argenx NV position performs unexpectedly, Quantum BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum BioPharma will offset losses from the drop in Quantum BioPharma's long position.

The idea behind argenx NV ADR and Quantum BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.